Carregant...
Extending the lymphoblastoid cell line model for drug combination pharmacogenomics
Combination drug therapies have become an integral part of precision oncology, and while evidence of clinical effectiveness continues to grow, the underlying mechanisms supporting synergy are poorly understood. Immortalized human lymphoblastoid cell lines (LCLs) have been proven as a particularly us...
Guardat en:
| Publicat a: | Pharmacogenomics |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Future Medicine Ltd
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8212852/ https://ncbi.nlm.nih.gov/pubmed/34044623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2020-0160 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|